Skip to main content

Caring for Patients in an Evidence-Limited World

Evidence-Based Medicine and Geriatrics

  • Reference work entry
  • First Online:
Geriatric Medicine

Abstract

Evidence-based medicine (EBM) integrates three elements: scientific evidence, clinician’s expertise, and patient’s goals and values. The practice of EBM requires a clinician to ask questions, acquire best evidence, appraise literature for validity and applicability, and apply it at the bedside. Specific to EBM in older adults, there is a relative lack of valid therapies and tools for decision-making. Most clinical trials have limited inclusion of older adults, particularly the oldest old and those with comorbidities, so results may be less applicable. This makes eliciting patients’ values and preferences more critical in decision-making. Knowledge of key EBM concepts and terminology and the ability to utilize the limited available evidence to treat older patients and to communicate decisions at the bedside are core competencies for geriatrics practitioners.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. How to read clinical journals: I. Why to read them and how to start reading them critically. Can Med Assoc J. 1981; 124(5):555–8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705173/.

  2. Oxman A, Sackett D, Guyatt G. Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA. 1993;270(17):2093–5.

    Article  CAS  PubMed  Google Scholar 

  3. Guyatt G, Rennie D, Meade MO, Cook DJ, editors. JAMA evidence user’s guides to the medical literature: a manual for evidence based clinical practice. 3rd ed. New York: McGraw-Hill; 2014.

    Google Scholar 

  4. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–13.

    Article  CAS  PubMed  Google Scholar 

  5. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Article  Google Scholar 

  6. Grady D, Hulley SB. Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med. 2000;133(12):999–1001.

    Article  CAS  PubMed  Google Scholar 

  7. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 1991;115(6):455–6.

    Article  CAS  PubMed  Google Scholar 

  8. Epstein AE, Hallstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA. 1993;270(20):2451–5.

    Article  CAS  PubMed  Google Scholar 

  9. Riggs BL, Hodgson SF, O’Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322(12):802–9.

    Article  CAS  PubMed  Google Scholar 

  10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255–64.

    Article  Google Scholar 

  11. Mooijaart SP, Broekhuizen K, Trompet S, et al. Evidence-based medicine in older patients: how can we do better? Neth J Med. 2015;73(5):211–8.

    CAS  PubMed  Google Scholar 

  12. Kitzman DW, Rich MW. Age disparities in heart failure research. JAMA. 2010;304(17):1950–1. https://doi.org/10.1001/jama.2010.1592.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98(21):2282–9.

    Article  CAS  PubMed  Google Scholar 

  14. Butrous H, Hummel SL. Heart failure in older adults. Can J Cardiol. 2016;32(9):1140–7. https://doi.org/10.1016/j.cjca.2016.05.005.

    Article  PubMed  Google Scholar 

  15. Jankowska EA, Vitale C, Uchmanowicz I, Tkaczyszyn M, Drozd M, Ponikowski P. Drug therapy in elderly heart failure patients. Eur Heart J Suppl. 2019;21(Suppl L):L8–L11. https://doi.org/10.1093/eurheartj/suz237.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217–24.

    Article  PubMed  PubMed Central  Google Scholar 

  17. García-Albéniz X, Hernán MA, Logan RW, Price M, Armstrong K, Hsu J. Continuation of annual screening mammography and breast cancer mortality in women older than 70 years. Ann Intern Med. 2020;172(6):381–9. https://doi.org/10.7326/M18-1199.

    Article  PubMed  Google Scholar 

  18. Dans AL, Dans LF, Guyatt GH, Richardson S. Users’ guides to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA. 1998;279(7):545–9.

    Article  CAS  PubMed  Google Scholar 

  19. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;(4):Art. No.: CD000028. https://doi.org/10.1002/14651858.CD000028.pub2.

  20. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA. 1994;272(24):1932–8.

    Article  CAS  PubMed  Google Scholar 

  21. Yoshikawa TT, Norman DC. Infectious disease in the aging: a clinical handbook. Totowa: Humana Press; 2001.

    Book  Google Scholar 

  22. Naughton BJ, Mylotte JM. Treatment guideline for nursing home-acquired pneumonia based on community practice. J Am Geriatr Soc. 2000;48(1):82–8.

    Article  CAS  PubMed  Google Scholar 

  23. Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications. J Am Geriatr Soc. 2000;48(10):1321–9.

    Article  CAS  PubMed  Google Scholar 

  24. Pelleg A, Ramaswamy R. Differential diagnoses in the setting of advanced age and multiple conditions. In: Chun A, editor. Geriatric practice. Cham: Springer; 2020. https://doi.org/10.1007/978-3-030-19625-7_7.

    Chapter  Google Scholar 

  25. Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987;237(4811):143–9.

    Article  CAS  PubMed  Google Scholar 

  26. Zanetti O, Solerte SB, Cantoni F. Life expectancy in Alzheimer’s disease (AD). Arch Gerontol Geriatr. 2009;49(Suppl 1):237–43. https://doi.org/10.1016/j.archger.2009.09.035.

    Article  PubMed  Google Scholar 

  27. Verduzco-Aguirre HC, Gomez-Moreno C, Chavarri-Guerra Y, Soto-Perez-de-Celis E. Predicting life expectancy for older adults with cancer in clinical practice: implications for shared decision-making. Curr Oncol Rep. 2019;21(8):68. https://doi.org/10.1007/s11912-019-0821-3.

    Article  PubMed  Google Scholar 

  28. Wei MY, Mukamal KJ. Multimorbidity, mortality, and long-term physical functioning in 3 prospective cohorts of community-dwelling adults. Am J Epidemiol. 2018;187(1):103–12. https://doi.org/10.1093/aje/kwx198.

    Article  PubMed  Google Scholar 

  29. Lu-Yao GL, Yao SL. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997;349(9056):906–10.

    Article  CAS  PubMed  Google Scholar 

  30. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J. 1994;308(6925):367–72.

    Article  CAS  Google Scholar 

  31. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pajewski NM, Berlowitz DR, Bress AP, et al. Intensive vs standard blood pressure control in adults 80 years or older: a secondary analysis of the systolic blood pressure intervention trial. Secondary analysis. J Am Geriatr Soc. 2020;68:496–504.

    Article  PubMed  Google Scholar 

  33. Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA III, Murphy DL. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study. Arch Gen Psychiatry. 1987;44(5):418–26.

    Article  CAS  PubMed  Google Scholar 

  34. Dubois B, Danze F, Pillon B, Cusimano G, Lhermitte F, Agid Y. Cholinergic-dependent cognitive deficits in Parkinson’s disease. Ann Neurol. 1987;22(1):26–30.

    Article  CAS  PubMed  Google Scholar 

  35. Davidson MH. Differences between clinical trial efficacy and real-world effectiveness. Am J Manag Care. 2006;12(15 Suppl):S405–11.

    PubMed  Google Scholar 

  36. Naidoo N, Nguyen VT, Ravaud P, et al. The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence. BMC Med. 2020;18:6. https://doi.org/10.1186/s12916-019-1476-5.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wieland D, Stuck AE, Siu AL, Adams J, Rubenstein LZ. Meta-analytic methods for health services research – an example from geriatrics. Eval Health Prof. 1995;18(3):252–82.

    Google Scholar 

  38. Applegate W, Deyo R, Kramer A, Meehan S. Geriatric evaluation and management: current status and future research directions. J Am Geriatr Soc. 1991;39(9 pt 2):2S–7S.

    CAS  PubMed  Google Scholar 

  39. Rodriguez RD, Schocken DD. Update on sick sinus syndrome, a cardiac disorder of aging. Geriatrics. 1990;45(1):26–30, 33–36.

    CAS  PubMed  Google Scholar 

  40. Drinka PJ, Gravenstein S, Krause P, Schilling M, Miller BA, Shult P. Outbreaks of influenza A and B in a highly immunized nursing home population. J Fam Pract. 1997;45(6):509–14.

    CAS  PubMed  Google Scholar 

  41. Anderson GD, Pak C, Doane KW, et al. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia. Ann Pharmacother. 1997;31(3):279–84.

    Article  CAS  PubMed  Google Scholar 

  42. Shannon M. Predictors of major toxicity after theophylline overdose. Ann Intern Med. 1993;119(12):1161–7.

    Article  CAS  PubMed  Google Scholar 

  43. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101(19):2239–46.

    Article  CAS  PubMed  Google Scholar 

  44. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med. 2002;162(5):561–8.

    Article  PubMed  Google Scholar 

  45. Heckerling PS, Tape TG, Wigton RS, et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med. 1990;113(9):664–70.

    Article  CAS  PubMed  Google Scholar 

  46. Mehr DR, Binder EF, Kruse RL, Zweig SC, Madsen RW, D’Agostino RB. Clinical findings associated with radiographic pneumonia in nursing home residents. J Fam Pract. 2001;50(11):931–7.

    CAS  PubMed  Google Scholar 

  47. Faggiano A, Del Prete M, Marciello F, Marotta V, Ramundo V, Colao A. Thyroid diseases in elderly. Minerva Endocrinol. 2011;36(3):211–31.

    CAS  PubMed  Google Scholar 

  48. Engberding N, Wenger NK. Acute coronary syndromes in the elderly. F1000Res. 2017;6:1791. https://doi.org/10.12688/f1000research.11064.1. PMID: 29043079; PMCID: PMC5627582.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Goch A, Misiewicz P, Rysz J, Banach M. The clinical manifestation of myocardial infarction in elderly patients. Clin Cardiol. 2009;32(6):E46–51. https://doi.org/10.1002/clc.20354. PMID: 19382276; PMCID: PMC6653078.

    Article  PubMed  Google Scholar 

  50. Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772–81. https://doi.org/10.1001/jama.2020.12134.

    Article  CAS  PubMed  Google Scholar 

  51. Warshaw G, Tanzer F. The effectiveness of lumbar puncture in the evaluation of delirium and fever in the hospitalized elderly. Arch Fam Med. 1993;2(3):293–7.

    Article  CAS  PubMed  Google Scholar 

  52. Vestal RE, Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979;26(2):181–6.

    Article  CAS  PubMed  Google Scholar 

  53. Ramaswamy R, Leipzig RM, Hung WW. Implementation of an evidence-based medicine curriculum in a fellowship program: can it influence clinical practice? Gerontol Geriatr Educ. 2020;11:1–10. https://doi.org/10.1080/02701960.2020.1777409.

    Article  Google Scholar 

  54. Epstein AS, Prigerson HG, O’Reilly EM, Maciejewski PK. Discussions of life expectancy and changes in illness understanding in patients with advanced cancer. J Clin Oncol. 2016;34(20):2398–403. https://doi.org/10.1200/JCO.2015.63.6696. Epub 2016 May 23.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182–92. https://doi.org/10.1001/jama.2011.1966.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28(10):973–7. https://doi.org/10.1212/wnl.28.10.973.

    Article  CAS  PubMed  Google Scholar 

  57. Lockett J, Sauma S, Radziszewska B, Bernard MA. Adequacy of inclusion of older adults in NIH-funded phase III clinical trials. J Am Geriatr Soc. 2019;67(2):218–22. https://doi.org/10.1111/jgs.15786. Epub 2019 Jan 29.

    Article  PubMed  Google Scholar 

  58. https://grants.nih.gov/policy/inclusion/lifespan.htm. Last accessed 20 Nov 2020.

  59. Orkaby AR, Driver JA, Ho Y, et al. Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA. 2020;324(1):68–78. https://doi.org/10.1001/jama.2020.7848.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46(3):399–424. https://doi.org/10.1080/00273171.2011.568786.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Mayo Clinic Statin Choice Decision Aid. https://statindecisionaid.mayoclinic.org. Last accessed 20 Nov 2020.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ravishankar Ramaswamy .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2024 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Ramaswamy, R., Leipzig, R.M. (2024). Caring for Patients in an Evidence-Limited World. In: Wasserman, M.R., Bakerjian, D., Linnebur, S., Brangman, S., Cesari, M., Rosen, S. (eds) Geriatric Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-74720-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74720-6_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74719-0

  • Online ISBN: 978-3-030-74720-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics